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It is now apparent that the gp701 envelope glycoprotein of murine leukemia 
virus (MuLV) is frequently expressed in mice that are not producing detectable 
amounts of MuLV (1-4). Furthermore,  at least two species of th'e gp70 molecule 
have been distinguished (5). These may be referred to provisionally as G~x-gp70, 
found on 129 thymocytes, and 0-gp70, found on C57BL/6 (B6) thymocytes, on the 
basis of the presence or absence of the G~x type-specificity. These gp70 variants 
are coded or regUlated by different unlinked genes; the thymocytes of an inbred 
mouse  may  express  either,  both,  or  neither  (5).  The  recogflition  of distinct 
variants of gp70 offers new opportunities for exploring the role of C-type viral 
genomes in oncogenesis. Thus, it should become possible: (a) to relate particular 
gp70  species to  particular  types  of ecotropic  and  xenotropic  C-type  viruses, 
whose oncogenic potentials may differ, and (b) to assess whether susceptibility 
to oncogenesis of any sort may be associated with constitutive expression of one 
or another gp70 species. For these reasons, as well as the general interest in this 
class of molecules, it seems important to identify other distinct gp70 variants of 
the mouse as a  basis for assessing their biological significance,  We report here 
the recognition of a  third variant which we tentatively name X-gp70. 
The three antisera used in this study are named and briefly described in Table 
I. All three are standard typing sera used in serological tests in this laboratory. 
All three are known to label virions in immunoelectronmicroscopy (6), although 
in the case of aTL (the usual serum used for TL typing;  a,  anti)  this reaction 
with  virions is almost certainly  due to  agp70 antibody generated  by the TL  + 
leukemia cells used for immunization and presumably has no relation to the TL 
antigens themselves. 
The  technique  of surface  iodination  of cells  bearing  gp70  and  detergent 
(Nonidet P-40 or NP-40) lysis of labeled cells, followed by immunoprecipitation 
of gp70 and subsequent sodium dodecyl sulfate-polyacrylamide gel electrophore- 
sis (SDS-PAGE) was carried out as before (4). 
Fig.  1 shows the results obtained with the three antisera in tests with three 
kinds  of A-strain  mouse cells: (a)  normal  thymocytes (which are  G~x  + (7) and 
produce few or no virions  visible in electromicrograph),  (b) the  transplanted 
G~x + (E. Stockert, personal communication) X-radiation leukemia RADA1 (as- 
* This work was supported in part by National Cancer Institute grants CA-08748, CA-16599, 
and CA-15297. 
MuLV glycoprotein of molecular weight in the range of 69,000-71,000 (sometimes called gp69/ 
71). 
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TABLE  I 
The Three Antisera 
Abbrevia-  Reference  Immunization  Description 
tion in text 
aNTD  5, 7, 8  (W/Fu  ×  BN)FI  rat anti-W/Fu  rat 
leukemia NTD  induced by MuLV 
aX.1  10 
aTL  13 
(BALB/c  x  B6)FI antiradiation leu- 
kemia BALB/c RLc~  1 
(B6 x A-TL-)FI anti-A strain sponta- 
neous leukemia ASL1 
Standard antiserum for C~x-typing by 
cytotoxicity assay; also  contains an- 
tibody to group-specific antigen  of 
gp70 
Standard typing serum for X.1 leuke- 
mia-associated antigen in the cyto- 
toxicity assay 
Standard typing serum for TL antigen 
on normal thymocytes and leukemia 
cells  (TL.1,2,3)  by cytotoxicity  assay 
cites cells), and (c) the transplanted  Gix- (E. Stockert, personal communication) 
spontaneous leukemia ASL1 (cells obtained from spleens of passage mice). Strain 
A  thymocytes are  G~x +,  and  both  leukemias  are  producing  virions;  thus,  as 
expected, aNTD (which contains antibody to gp70 group-specific antigen [5, 8]) 
precipitated gp70 from all three cell types (Fig. 1 a-c). But aX. 1 (Fig. 1 d-f) and 
aTL (Fig.  1 g-i) precipitated gp70 only from the two leukemia lines,  not from 
thymocytes. 2 Therefore the two leukemias express a  gp70 variant which is not 
detectable on A-strain thymocytes. It cannot be Gxx-gp70, and it is identified by 
both aX.1 and aTL. Provisionally, we propose to call this gp70 variant 'X-gp70.' 
A more systematic nomenclature for members of the gp70 molecular species will 
be called for in due course. In the meantime we chose the arbitrary and neutral 
prefix  'X'  because  X-gp70  was  first  recognized  with  X.1  antiserum.  The  X.1 
system (10) was so named because antibodies to X. 1 antigens are formed by mice 
(i.e., within the species), and the X. 1 immune response is under the control oflr 
genes, which suggested an interpretation  of the 'X' antigens which Gorer et al. 
(11) demonstrated  serologically in mouse leukemia cells many years ago. The 
presence of aX-gp70 antibody in the aTL antiserum is explained by the fact that 
the TL  + leukemia used for producing this particular TL antiserum is ASL1. 
Fig.  2 summarizes  studies  with  RADA1 leukemia  cells which demonstrate 
that two distinct variants of gp70 are carried by the A-strain leukemias.  This 
conclusion is based on the argument that:  (a) if aX. 1 and aTL identify a  type- 
specific gp70 (X-gp70) then removal of this gp70 by immunoprecipitation  with 
either antiserum should leave in solution the other gp70, precipitable in turn by 
reaction  with  aNTD;  and  (b),  on  the  other  hand,  precipitation  with  aNTD 
should leave nothing that can subsequently be precipitated by aX. 1 and aTL. 
Both  aX.1  and  aTL  remove  gp70  precipitable  by  either  antiserum  (Fig.  2 
e,f,h,i),  but leave gp70 precipitable  by aNTD (Fig.  2 b,c),  which confirms (a) 
above; aNTD removes all gp70 precipitable by any of the three antisera (Fig. 2 
a,d,g),  illustrating  that (b)  also is correct.  Thus RADA1 leukemia cells carry 
two species of gp70, one of which can be accounted for as the Gix-gp70,  which is 
present on A-strain thymocytes, and another which is not present on A thymo- 
cytes  and  which  we  call  X-gp70.  The  gp70  discovered  on  B6  thymocytes in 
2 The "tumor-associated antigen" which Yu and Cohen (9) observed with aTL serum is doubt- 
less this gp70. ? 
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FIG.  1.  SDS-PAGE  patterns  of immunoprecipitates  from NP-40  lysates  of surface-iodi- 
nated  cells  (A  thymocytes,  RADAI,  and  ASL1)  formed  by different  antisera  (~NTD  or 
normal rat serum, NRS: a,b,c; ~X.1 or normal BALB/c mouse serum, NMS: ki,e,f; and ~TL 
or NMS: g,h,i).  The patterns  are  plotted together  from parallel  gels.  The electrophoresis 
conditions were previously described  (4).  The anode is on the right.  The markers used for 
estimation  of molecular weights  were  14C-amino acid-labeled  Gross-MuLV proteins,  and 
their locations  in parallel  gels  are  indicated  at the  top of each  column.  125I-labeled  cell- 
surface components are identified by arrows: gp70, cell-surface gp70; TL, thymus leukemia 
antigen (14); a, probably a nov_specifically precipitated protein of the actin type which is a 
major host cell constituent (15); n, probably a cell-surface gp70 precipitated by agp70 occur- 
ring naturally in the NMS pool; ~2M,  ~2-microglobulin associated with TL antigen  (16). 
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Fla.  2.  Sequential  immunoprecipitations.  The  three  column  headings  (<Previously 
cleared with aNTD, aX.1, or aTL') refer to the preparatory treatment of each antiserum. 
This consisted in reacting NP-40 lysates of surface-iodinated  RADA1 cells with an excess of 
the antiserum indicated  by the heading, followed by anti-immunoglobulin  at equivalent 
concentration,  both predetermined by titration. Control experiments indicated that such a 
'clearing' step did not affect detection of  a second antigen exemplified by precipitation of H-2 
antigen before and after <clearing' (data not shown). Peaks of gp70 are visible in panels b 
and c, In panels g and h precipitation of TL antigen is visible against a background peak of 
autoprecipitating cell protein near the same position in the gel (cf. Fig. 1). 
previous work (5) is neither Gtx-gp70, because B6 thymocytes are Gin- (7), nor X- 
gp70,  because  aX. 1 precipitates no gp70 from B6 thymocytes (data not given). 
Provisionally, the notation 0-gp70 seems appropriate for this other gp70, the '0' 
signifying that no type specificity has yet been established for this molecule. 
Comment 
This report  is  limited  to results  with  cells of A-strain  origin  because these 
findings, taken in conjuction with our earlier data, are adequate to establish the 
existence of the third type of MuLV gp70. It is known that G,x-gp70 and 0-gp70 
are  coded  or specified by unlinked  loci  and  so constitute  two discrete  genetic 
systems, possibly two different integrated MuLV genomes. It would seem likely 
that X-gp70 constitutes a third independent locus, but proof of this is lacking. In 
studies of several mouse strains  other than  A,  we have found X-gp70 only on 
leukemia cells which are producing virus or on cells from strains such as AKR 
which produce large amounts  of virus; thus  AKR thymocytes express X-gp70. 
But although the X-gp70  + phenotype appears to be associated with productive 
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thymocytes of  BALB/c mice do not have precipitable  X,gp70; yet the BALB/c 
radiation  leukemia RLc~  1 (Table  I)  is  X-gp70  + (data  not  shown). G~x-  mice  simi- 
Larly  may produce G~x  + leukemias, and in this  respect  there is a resemblance 
between the X-gp70 and G~x-gp70 systems. However, Gxx-gp70,  unlike X-gp70 
(on  present evidence),  can  be  expressed without  productive  infection.  [Aoki and 
:oworkers (6, 12)  find  that  RADA1 leukemia cells  produce  three  types  ofvirions 
identifiable  by immunoelectronmicroscopy with a set of  typing sera including 
~X.1. This accords  with the occurrence of  at least  two gp70 species  on RADA1 
cells,  since  these visual  distinctions  may well be largely  due to antigenic  vari- 
ants  of  gp70.]  The most pointed distinction  between GLx-gp70  and 0-gp70  on the 
one  hand and X-gp70 on the other  is  that expression  of  the  former  two variants 
is  geared to physiological  controls  governing the differentiation  of  T cells  and 
need  not  be accompanied by virus  production.  So  far  this  has not  been observed 
in  the.case  of  X-gp70. 
Summary 
Three  variants  of  the  gp70  envelope component of  MuLV are  now  recognizable 
serologically:  G~x-gp70,  0-gp70,  and X-gp70. The last  of  these,  X-gp70, has  so  far 
been found only in mice or  cells  producing abundant C-type virus.  This distin- 
guishes X-gp70, provisionally,  from the G~x-gp70 and 0-gp70 variants,  each of 
which can be expressed on normal thymocytes without accompanying virus 
production,  as exemplified by mouse strains  129 and B6, respectively.  The X- 
gp70 genotype, however, is not limited  to strains  of  mice-producing abundant 
virus,  because X-gp70  + leukemias occur  in  strains  of  mice which do  not produce 
a  great  deal  of  virus  and whose  thymocytes  and  other  tissues  are  X-gp70-;  this  is 
analogous to the appearance of  G~x  + leukemias in G~x-  mouse strains. 
We thank Doctors H. Sato for  the aX.l serum, E. Stockert for  the aNTD  serum, U. Hammerling 
for  rabbit antirat Ig serum, and Mrs. J. Seguin for  valuable technical  assistance. 
Received for publication 22 December 1975. 
References 
1.  Strand, M.,  F.  Lilly, and J.  T. August.  1974. Genetic control of the expression of 
routine leukemia virus proteins in tissues of normal, young adult mice. Cold Spring 
Harbor Syrup. Quant. Biol.  34:1117. 
2.  Del Villano, B. C.,  B. Nave, B. P. Croker, R. A. Lerner, and F. Dixon.  1975. The 
oncornavirus glycoprotein gp69/71: a constituent of the surface of normal and malig- 
nant thymocytes. J. Exp. ]Pied. 141:172. 
3.  Obata, Y., H. Ikeda, E. Stockert, and E. A. Boyse. 1975. Relation of Gjx antigen of 
thymocytes  to envelope glycoprotein of  murine leukemia virus. J. Exp. Med. 141:188. 
4.  Tung, J-S., E. S. Vitetta, E. Fleissner, and E. A. Boyse. 1975. Biochemical evidence 
linking the Gsx thymocyte surface antigen to the gp69/71 envelope glycoprotein of 
murine leukemia virus. J. Exp. Med.  141:198. 
5.  Tung, J-S., E. Fleissner, E. S. Vitetta, and E. A. Boyse. 1975. Expression of murine 
leukemia virus envelope glycoprotein gp69/71 on mouse thymocytes: evidence for two 
structural variants distinguished by presence versus absence of G~x antigen. J. Exp. 
Med.  142:518. 974  TUNG  ET  AL.  BRIEF  DEFINITIVE  REPORT 
6.  Aoki, T., R. J. Huebner, K. S. S. Chang, M. M. Sturm, and M. Liu. 1974. Diversity of 
envelope antigens on murine type-C RNA viruses. J. Natl. Cancer Inst.  52:1189. 
7.  Stockert, E.,  L. J.  Old, and E, A. Boyse. 1971. The G~x system: a  cell surface allo- 
antigen associated with murine leukemia virus: implications regarding chromosomal 
integration of the viral genome. J. Exp. Med.  133:1334. 
8.  Geering, G.,  L.  J.  Old,  and E.  A.  Boyse.  1966. Antigens of leukemias induced by 
naturally occurring murine leukemia virus: their relation to the antigens of Gross 
virus and other murine leukemia viruses. J. Exp. Med.  124:753. 
9.  Yu,  A.,  and  E.  P.  Cohen.  1974. Studies  on  the  effect of specific antisera  on the 
metabolism of cellular antigens. I. Isolation of thymus leukemia antigens. J. Immu- 
nol.  112:1285. 
10.  Sato, H., E. A. Boyse, T. Aoki, C. Iritani, and L. J. Old. 1973. Leukemia-associated 
transplantation antigens related to murine leukemia virus. The X.1 system: immune 
response controlled by a locus linked to H-2. J. Exp. Med.  138:593. 
11.  Gorer, P. A., M. A. Tuffrey, and J. R. Batchelor. 1962. Serological studies on the X 
antigen. Ann. N. Y. Acad. Sci.  101:5. 
12.  Aoki, T. 1974. Murine type-C RNA viruses: a proposed reclassification, other possible 
pathogenicities, and a new immunologic function. J. Natl. Cancer Inst.  52:1029. 
13.  Boyse, E. A., and L. J. Old. 1969. Some aspects of normal and abnormal cell surface 
genetics. Annu. Rev. Genet. 3:269. 
14.  Vitetta, E. S., J. W. Uhr, and E. A. Boyse. 1972. Isolation and characterization of H-2 
and TL alloantigens from the surface of mouse lymphocytes. Cell. Immunol. 4:187. 
15.  Ikeda, H., W. Hardy, Jr., E. Tress, and E. Fleissner. 1975. Chromatographic separa- 
tion and antigenic analysis of proteins of the oncornaviruses. V. Identification of a 
new murine viral protein, pl5(E). J. Virol.  16:53. 
16.  Vitetta, E. S., J.  W. Uhr, and E. A. Boyse. 1975. Association of a  B2-microglobulin- 
like  subunit  with  H-2  and  TL alloantigens  on  murine  thymocytes. J.  Immunol. 
114:252. 